Manitou Investment Management Ltd. Has $675,000 Position in CME Group Inc. (NASDAQ:CME)

Manitou Investment Management Ltd. increased its position in CME Group Inc. (NASDAQ:CME) by 7.1% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 3,060 shares of the financial services provider’s stock after acquiring an additional 203 shares during the quarter. CME Group accounts for 0.1% of Manitou Investment Management Ltd.’s holdings, making the stock its 22nd largest position. Manitou Investment Management Ltd.’s holdings in CME Group were worth $675,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CME. Salomon & Ludwin LLC bought a new stake in CME Group in the first quarter valued at approximately $28,000. Y.D. More Investments Ltd bought a new stake in CME Group in the second quarter valued at approximately $36,000. Thurston Springer Miller Herd & Titak Inc. boosted its holdings in CME Group by 62.2% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after acquiring an additional 74 shares during the last quarter. McClarren Financial Advisors Inc. boosted its holdings in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares during the last quarter. Finally, Asset Dedication LLC boosted its holdings in CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Trading Down 0.8 %

NASDAQ CME opened at $225.36 on Friday. The firm has a market capitalization of $81.15 billion, a P/E ratio of 23.70, a PEG ratio of 5.72 and a beta of 0.55. The business has a fifty day simple moving average of $220.36 and a 200 day simple moving average of $209.34. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. CME Group’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.25 EPS. On average, analysts predict that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio is presently 48.37%.

Analyst Upgrades and Downgrades

CME has been the topic of a number of research analyst reports. Keefe, Bruyette & Woods increased their price target on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. The Goldman Sachs Group increased their price target on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Piper Sandler increased their price target on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Monday. Citigroup increased their price target on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday, October 24th. Finally, Morgan Stanley increased their price target on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and an average target price of $222.73.

Insider Activity

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,221 shares of company stock valued at $3,351,895 in the last ninety days. 0.30% of the stock is currently owned by insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.